A Pandemic Therapeutics Centre will be established in Melbourne to rapidly develop new life-saving treatments, further expanding on Melbourne’s reputation as a global leader in medical research.
Renowned US-based e-commerce innovator Fanplayr has chosen Melbourne to open its Asia Pacific headquarters, which will create highly skilled jobs in the state’s thriving tech sector.
Clean technology innovator DiviGas has chosen to move its global headquarters from Singapore to Melbourne, where it will further develop its world-leading hydrogen capture solutions.
The Victorian Government is backing industry development of next-generation quiet electric aviation technology to assist Victoria to meet its 50 per cent renewable energy target by 2030, encouraging the decarbonisation of logistics and transport networks.
Australia’s capability to manufacture mRNA vaccines onshore has been secured with Moderna and the Victorian Government finalising arrangements for this world-leading biotech research organisation to establish its mRNA vaccine manufacturing facility and Regional Research Centre in Victoria.
The UK’s acclaimed retirement technology provider Smart Pension has chosen Melbourne’s thriving fintech sector for its Australian base, where it will work with partners to deliver innovative digital retirement savings solutions across the country.
With an eye for expansion, global online education platform Coursera has chosen Melbourne to base its APAC headquarters.
Consulting giant, Ernst & Young (EY) will establish its new Service Delivery Centre in Ballarat, 75 minutes west of Melbourne.
One of the world’s biggest airlines is gearing up to restart and grow direct services between Melbourne and San Francisco, providing more opportunities than ever for businesses to expand their operations in Melbourne’s thriving multi-sector ecosystem.
Europe’s largest public research organisation has chosen to establish a representative office for Oceania in Melbourne, in a further boost to Victoria’s globally renowned R&D sector.
Monash University has achieved gold standard status in one of the world’s most prestigious university rankings, further cementing its global reputation for research and education excellence.
In a further boost to Victoria’s mRNA and medical research advancements, mRNA Victoria will collaborate with Pfizer’s Centers for Therapeutic Innovation (CTI) and RNA Accelerator to advance critical therapeutic and vaccine research and development.